{"id":14566,"date":"2023-09-17T23:16:10","date_gmt":"2023-09-17T23:16:10","guid":{"rendered":"https:\/\/kraios.app\/news\/saglik\/2023\/09\/17\/kemik-iligi-bagisi-sayesinde-kansere-elveda-dediler\/"},"modified":"2023-09-17T23:16:10","modified_gmt":"2023-09-17T23:16:10","slug":"kemik-iligi-bagisi-sayesinde-kansere-elveda-dediler","status":"publish","type":"post","link":"https:\/\/kraios.app\/news\/saglik\/2023\/09\/17\/kemik-iligi-bagisi-sayesinde-kansere-elveda-dediler\/","title":{"rendered":"Kemik ili\u011fi ba\u011f\u0131\u015f\u0131 sayesinde kansere “elveda” dediler"},"content":{"rendered":"

<\/p>\n

\n

Bilkent \u015eehir Hastanesi Onkoloji Hastanesi’nde karde\u015flerinin ba\u011f\u0131\u015f\u00e7\u0131 olmas\u0131 sonucu yap\u0131lan kemik ili\u011fi nakliyle yeni bir ya\u015fama ba\u015flayan matematik \u00f6\u011fretmeni Ebru Ko\u00e7ak ve \u00fcniversite \u00f6\u011frencisi Mustafa Hayrullah Zoymano\u011flu, kanseri yenme umuduyla bekleyen hastalar i\u00e7in k\u00f6k h\u00fccre ba\u011f\u0131\u015f\u0131 \u00e7a\u011fr\u0131s\u0131nda bulundu.<\/p>\n

Her y\u0131l eyl\u00fcl ay\u0131n\u0131n \u00fc\u00e7\u00fcnc\u00fc cumartesi g\u00fcn\u00fc g\u00f6n\u00fcll\u00fc kemik ili\u011fi ba\u011f\u0131\u015f\u00e7\u0131lar\u0131na te\u015fekk\u00fcr etmek amac\u0131yla D\u00fcnya Kemik \u0130li\u011fi Ba\u011f\u0131\u015f\u00e7\u0131lar\u0131 G\u00fcn\u00fc olarak kutlan\u0131yor. Ba\u011f\u0131\u015f\u00e7\u0131lar, verdikleri \u00fc\u00e7 t\u00fcp kanla kanserle m\u00fccadele eden bir hastaya yeni bir ya\u015fam hediye edebiliyor.<\/p>\n

T\u00fcrkiye’de l\u00f6semi, lenfoma, multipl miyelom gibi hematolojik kanserlerin tedavisi ve kemik ili\u011fi nakillerini ger\u00e7ekle\u015ftiren en donan\u0131ml\u0131 merkezlerden biri de Bilkent \u015eehir Hastanesi Onkoloji Hastanesi Hematoloji Klini\u011fi’nde yer al\u0131yor. Bu klinikte y\u00fcr\u00fct\u00fclen tedavi ve nakiller sayesinde bir\u00e7ok hasta sa\u011fl\u0131\u011f\u0131na kavu\u015fma \u015fans\u0131n\u0131 yakalayabiliyor.<\/p>\n

\"\"<\/p>\n

“24 Kas\u0131m \u00d6\u011fretmenler G\u00fcn\u00fc’nde erkek karde\u015fimden nakil yap\u0131ld\u0131”<\/h3>\n

Hastanedeki kemik ili\u011fi nakliyle akut l\u00f6semiyi atlatan 25 ya\u015f\u0131ndaki matematik \u00f6\u011fretmeni Ebru Ko\u00e7ak AA muhabirine yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, 1,5 y\u0131l \u00f6nce okulda \u00f6\u011frencilerine ders anlat\u0131rken konu\u015fmakta zorland\u0131\u011f\u0131n\u0131, bacaklar\u0131nda \u015fi\u015fli\u011fi fark etmesi \u00fczerine doktora ba\u015fvurdu\u011funu anlatt\u0131.<\/p>\n

L\u00f6semi tan\u0131s\u0131n\u0131 Nisan 2022’de ald\u0131\u011f\u0131n\u0131 ve h\u0131zla tedaviye ba\u015fland\u0131\u011f\u0131n\u0131 belirten Ko\u00e7ak, duygular\u0131n\u0131 \u015fu s\u00f6zlerle dile getirdi:<\/p>\n

“Hastal\u0131\u011f\u0131m\u0131 ba\u015flang\u0131\u00e7ta kabul edemedim. Sa\u00e7lar\u0131m\u0131 kaybetmeye ba\u015flamamla durumumu kabul ettim ve tedavimle m\u00fccadeleye ba\u015flad\u0131m. Kemik ili\u011fi nakli a\u015famas\u0131na geldi\u011fimde \u00f6nce bir ba\u011f\u0131\u015f\u00e7\u0131 bulunmu\u015ftu ama sonras\u0131nda dokular\u0131n\u0131n tam uymad\u0131\u011f\u0131 saptand\u0131. \u00c7ok \u00fcz\u00fclm\u00fc\u015ft\u00fcm.<\/p>\n

Son \u00e7are 17 ya\u015f\u0131ndaki karde\u015fimdi. Ya\u015f\u0131 tam uymad\u0131\u011f\u0131 i\u00e7in hocalar\u0131m\u0131z \u00f6nce karde\u015fimden almak istemedi, bu s\u00fcre\u00e7te 2-3 ay bekledim. Sonras\u0131nda ise karde\u015fimin durumu uygun bulununca kemik ili\u011fi nakli ger\u00e7ekle\u015fti. Ben hep o nakil g\u00fcn\u00fcn\u00fc beklemi\u015ftim, \u00e7ok \u015f\u00fck\u00fcr oldu hatta ge\u00e7en y\u0131l 24 Kas\u0131m \u00d6\u011fretmenler G\u00fcn\u00fc’nde nakil yap\u0131ld\u0131. \u0130yile\u015fme s\u00fcrecini de atlatt\u0131m ve \u015fu an hayat\u0131ma kald\u0131\u011f\u0131m yerden devam ediyorum. \u00d6\u011frencilerimi \u00e7ok \u00f6zledim, onlara en k\u0131sa s\u00fcrede geri d\u00f6nebilmeyi umut ediyorum.”<\/p>\n

Ko\u00e7ak, sa\u011fl\u0131kl\u0131 t\u00fcm bireylere, “L\u00f6semi tedavisinin sonlanabilmesi i\u00e7in kemik ili\u011fi nakli \u015fart. Benim gibi bir\u00e7ok hasta \u015fu an nakil olabilmek i\u00e7in bekliyor. Bu nedenle l\u00fctfen ba\u011f\u0131\u015f\u00e7\u0131 olmaktan \u00e7ekinmeyin.” \u00e7a\u011fr\u0131s\u0131nda bulundu.<\/p>\n

\"\"<\/p>\n

“Ablam tek karde\u015fim, \u015fans eseri ili\u011fimiz y\u00fczde 100 uyumlu \u00e7\u0131kt\u0131”<\/h3>\n

Marmara \u00dcniversitesi Elektrik Elektronik M\u00fchendisli\u011fi B\u00f6l\u00fcm\u00fc \u00f6\u011frencisi, 23 ya\u015f\u0131ndaki Mustafa Hayrullah Zoymano\u011flu da l\u00f6semiye yakalanmas\u0131 nedeniyle 3. s\u0131n\u0131fta e\u011fitimini dondurdu\u011funu s\u00f6yledi.<\/p>\n

Zoymano\u011flu, Ekim 2022’de tan\u0131 ald\u0131\u011f\u0131n\u0131, Bilkent \u015eehir Hastanesi’nde h\u0131zla tedavisine ba\u015fland\u0131\u011f\u0131n\u0131 belirterek, \u015f\u00f6yle konu\u015ftu:<\/p>\n

“Ablam\u0131n kemik ili\u011fi ba\u011f\u0131\u015f\u0131 sayesinde ocak ay\u0131nda nakil oldum. Bu sayede l\u00f6semiyi yendim. Ba\u015flang\u0131\u00e7ta \u00e7ok s\u0131k kontrole geliyordum, \u015fu anda ayda bir doktor kontrollerim s\u00fcr\u00fcyor. Ablam benim tek karde\u015fim, \u015fans eseri ili\u011fimiz y\u00fczde 100 uyumlu \u00e7\u0131kt\u0131. Aram\u0131zdaki ba\u011f\u0131 bu s\u00fcre\u00e7 \u00e7ok daha g\u00fc\u00e7lendirdi. Hastalar tedavi s\u00fcrecinde zorlu bir s\u00fcre\u00e7ten ge\u00e7iyor, en s\u0131k\u0131nt\u0131l\u0131 k\u0131s\u0131m da nakil i\u00e7in beklemek. Bu nedenle sa\u011fl\u0131kl\u0131 herkesin k\u00f6k h\u00fccre ba\u011f\u0131\u015f\u00e7\u0131s\u0131 olmas\u0131n\u0131 \u00f6neriyorum, benim kadar \u015fansl\u0131 olmayan bir\u00e7ok hasta var.”<\/p>\n

Okulunu \u00e7ok \u00f6zledi\u011fini de dile getiren Zoymano\u011flu, e\u011fitimini bir an \u00f6nce tamamlayabilmek istedi\u011fini kaydetti.<\/p>\n

\"\"<\/p>\n

“Bir hastan\u0131n nakil i\u00e7in karde\u015fiyle tam uyumlu olma \u015fans\u0131 y\u00fczde 25”<\/h3>\n

Hematoloji Klini\u011fi ve Kemik \u0130li\u011fi Transplantasyon \u00dcnitesi Sorumlusu Prof. Dr. G\u00fcls\u00fcm \u00d6zet de kemik ili\u011fi ba\u011f\u0131\u015f\u0131 ve naklinin \u00f6nemine i\u015faret ederek, “Kemik ili\u011fi nakli \u00f6zellikle hematolojik hastalarda ba\u015far\u0131yla kulland\u0131\u011f\u0131m\u0131z bir tedavi se\u00e7ene\u011fi. \u00c7\u00fcnk\u00fc kemik ili\u011finde hem kendini yenileyen hem de olgun kan h\u00fccrelerine d\u00f6n\u00fc\u015febilen k\u00f6k h\u00fccreler mevcut.” dedi.<\/p>\n

\u00d6zet, kemik ili\u011fi nakillerinin \u00e7o\u011funun periferik kandan toplanan k\u00f6k h\u00fccrelerle yap\u0131ld\u0131\u011f\u0131n\u0131 ve nakillerin otolog (hastan\u0131n kendi k\u00f6k h\u00fccrelerinin kullan\u0131lmas\u0131) veya allojenik (bir ba\u015fka ki\u015finin k\u00f6k h\u00fccrelerinin kullan\u0131lmas\u0131) olmak \u00fczere iki y\u00f6ntemle ger\u00e7ekle\u015ftirildi\u011fini anlatt\u0131.<\/p>\n

Bu nakillerin hastalar\u0131n \u015fifa bulma \u015fans\u0131n\u0131 \u00f6nemli oranda art\u0131rd\u0131\u011f\u0131n\u0131 vurgulayan \u00d6zet, s\u00f6zlerini \u015f\u00f6yle s\u00fcrd\u00fcrd\u00fc:<\/p>\n

“Allojenik k\u00f6k h\u00fccre nakilleri hastalar\u0131n karde\u015fi, akrabas\u0131 veya akraba d\u0131\u015f\u0131 bir ki\u015fiden yap\u0131l\u0131yor. \u00c7ok nadiren de kordon kan\u0131n\u0131 kullan\u0131yoruz. Bir hastan\u0131n nakil i\u00e7in karde\u015fiyle dokusunun tam uyumlu olma \u015fans\u0131 y\u00fczde 25. Bu olmad\u0131\u011f\u0131nda akrabalar\u0131ndan veya akraba d\u0131\u015f\u0131 g\u00f6n\u00fcll\u00fc vericilerden uygun ba\u011f\u0131\u015f\u00e7\u0131y\u0131 aramaya ba\u015fl\u0131yoruz. Eskiden g\u00f6n\u00fcll\u00fc vericileri d\u00fcnyadaki verici bankalar\u0131ndan temin ediyorduk. Ancak 2015’te \u00fclkemizde T\u00dcRK\u00d6K’\u00fcn devreye al\u0131nmas\u0131 sayesinde \u00f6nceden yurt d\u0131\u015f\u0131ndan g\u00f6n\u00fcll\u00fc k\u00f6k h\u00fccre ba\u011f\u0131\u015f\u00e7\u0131s\u0131 getirirken \u015fimdi g\u00f6n\u00fcll\u00fc ba\u011f\u0131\u015f\u00e7\u0131lar\u0131m\u0131z\u0131n h\u00fccreleriyle yurt d\u0131\u015f\u0131nda nakiller yap\u0131labiliyor.”<\/p>\n

\"\"<\/p>\n

18-50 ya\u015f aras\u0131ndaki sa\u011fl\u0131kl\u0131 her birey k\u00f6k h\u00fccre ba\u011f\u0131\u015f\u00e7\u0131s\u0131 olabilir<\/h3>\n

Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 ve T\u00fcrk K\u0131z\u0131lay i\u015f birli\u011finde ba\u015flat\u0131lan T\u00dcRK\u00d6K projesinin \u00e7ok \u00f6nemli oldu\u011funa i\u015faret eden \u00d6zet, “18-50 ya\u015f aras\u0131ndaki sa\u011fl\u0131kl\u0131 her birey T\u00fcrk K\u0131z\u0131laya ba\u015fvurarak g\u00f6n\u00fcll\u00fc k\u00f6k h\u00fccre ba\u011f\u0131\u015f\u00e7\u0131s\u0131 olabilir. Ba\u011f\u0131\u015f\u00e7\u0131lardan ilk etapta sadece \u00fc\u00e7 t\u00fcp kan al\u0131n\u0131yor ve kan\u0131nda incelenen doku gruplar\u0131 bilgi bankas\u0131nda saklan\u0131yor. Bu dokularla nakil bekleyen hastalar\u0131n durumlar\u0131 T\u00dcRK\u00d6K \u00fczerinde kar\u015f\u0131la\u015ft\u0131r\u0131l\u0131yor ve bir hastayla uyu\u015ftu\u011fu d\u00fc\u015f\u00fcn\u00fclen verici bulunmas\u0131 durumunda T\u00fcrk K\u0131z\u0131lay arac\u0131l\u0131\u011f\u0131yla ba\u011f\u0131\u015f\u00e7\u0131ya ula\u015f\u0131l\u0131yor.” dedi.<\/p>\n

Prof. Dr. \u00d6zet, ba\u011f\u0131\u015f\u00e7\u0131n\u0131n kabul etmesi durumunda merkezlerde detayl\u0131 tetkiklerin yap\u0131ld\u0131\u011f\u0131n\u0131, doku grubu tam uyarsa 5 g\u00fcnl\u00fck a\u015f\u0131laman\u0131n ard\u0131ndan aferez cihaz\u0131yla k\u00f6k h\u00fccrelerin topland\u0131\u011f\u0131n\u0131 aktararak, “Ba\u011f\u0131\u015f\u00e7\u0131 olmak hi\u00e7 zor de\u011fil, ki\u015fiye verece\u011fi hi\u00e7bir zarar yok. K\u00f6k h\u00fccreleri kendilerini k\u0131sa zamanda yeniledi\u011fi i\u00e7in ba\u011f\u0131\u015f yapt\u0131\u011f\u0131nda azalm\u0131yor.” diye konu\u015ftu.<\/p>\n

K\u00f6k h\u00fccre ba\u011f\u0131\u015f\u0131 konusunda toplumsal fark\u0131ndal\u0131\u011f\u0131n artmas\u0131 gerekti\u011finin alt\u0131n\u0131 \u00e7izen \u00d6zet, “Sadece \u00fc\u00e7 t\u00fcp kanla verici aday\u0131 olmak, sonras\u0131nda e\u011fer uyumlu hasta bulunursa bir ya\u015fam\u0131 kurtarmak \u00e7ok k\u0131ymetli. Vericiler a\u00e7\u0131s\u0131ndan bakt\u0131\u011f\u0131n\u0131zda da bir ba\u015fkas\u0131n\u0131n hayat\u0131n\u0131 kurtarmak herkese nasip olacak bir \u015fey de\u011fil, onlar i\u00e7in de \u00e7ok b\u00fcy\u00fck bir mutluluk.” ifadesini kulland\u0131.<\/p>\n

\u00d6zet, baz\u0131 verici adaylar\u0131n\u0131n tam nakil a\u015famas\u0131nda k\u00f6k h\u00fccre ba\u011f\u0131\u015f\u0131ndan vazge\u00e7ti\u011fine de de\u011finerek, bunun hastalar i\u00e7in b\u00fcy\u00fck bir zaman kayb\u0131 ve umutsuzlu\u011fa yol a\u00e7t\u0131\u011f\u0131n\u0131, bu nedenle ba\u011f\u0131\u015f\u00e7\u0131lar\u0131n ger\u00e7ekten ba\u011f\u0131\u015f\u00e7\u0131 olma karar\u0131n\u0131 vererek hareket etmesi gerekti\u011fini vurgulad\u0131.<\/p>\n

“T\u00fcrkiye, kemik ili\u011fi naklinde \u00e7ok ba\u015far\u0131l\u0131 bir noktada”<\/h3>\n

Hastanenin Kemik \u0130li\u011fi Transplantasyon \u00dcnitesi’nde 4 y\u0131lda yakla\u015f\u0131k 270 kemik ili\u011fi nakli ger\u00e7ekle\u015ftirildi\u011fini, merkezin tam donan\u0131ml\u0131 hizmet verdi\u011fini dile getiren \u00d6zet, nakil olan hastalar\u0131n uzun d\u00f6nem d\u00fczenli kontrollerle takip edildi\u011fini ve bu sayede sa\u011fl\u0131kl\u0131 t\u00fcm bireyler gibi ya\u015fam\u0131n\u0131 s\u00fcrd\u00fcrebildiklerini kaydetti.<\/p>\n

\u00d6zet, “T\u00fcrkiye, kemik ili\u011fi naklinde \u00e7ok ba\u015far\u0131l\u0131 bir noktada. Gerek kamu gerekse \u00f6zelde kemik ili\u011fi nakil \u00fcniteleri gerekli say\u0131 ve niteli\u011fe ula\u015fm\u0131\u015f durumda. Ge\u00e7mi\u015fte hastalara s\u0131ra gelmemesi, baz\u0131 hastalar\u0131n yurt d\u0131\u015f\u0131na gitmesi gibi durumlar ya\u015fan\u0131yordu. G\u00fcn\u00fcm\u00fczde ise biz \u00fclkemize gelen yabanc\u0131 hastalara nakil yapabiliyoruz. \u00dclkemizde y\u0131lda 5 binin \u00fczerinde nakil yap\u0131l\u0131yor.” de\u011ferlendirmesinde bulundu.<\/p>\n


\n
\n Anadolu Ajans\u0131 web sitesinde, AA Haber Ak\u0131\u015f Sistemi (HAS) \u00fczerinden abonelere sunulan haberler, \u00f6zetlenerek yay\u0131mlanmaktad\u0131r. Abonelik i\u00e7in l\u00fctfen ileti\u015fime ge\u00e7iniz.<\/b>
\n <\/a>
\n <\/span>\n <\/div>\n